HOB Biotech Group Corp.,Ltd (SHA:688656)

Market Cap	6.14B +11.0%
Revenue (ttm)	399.65M +1.3%
Net Income	21.74M -37.2%
EPS	0.34 -39.8%
Shares Out	62.68M
PE Ratio	287.76
Forward PE	n/a
Dividend	0.20 (0.21%)
Ex-Dividend Date	May 29, 2026

Volume	349,661
Open	96.33
Previous Close	96.85
Day's Range	95.98 - 98.79
52-Week Range	94.00 - 217.00
Beta	-0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About SHA:688656

HOB Biotech Group Corp.,Ltd. operates as an in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immune assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. HOB Biotech Group Corp.,Ltd was founded in 2009 and is based in Suzhou, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 546
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688656

Financial Performance

In 2025, SHA:688656's revenue was 398.40 million, a decrease of -0.98% compared to the previous year's 402.34 million. Earnings were 23.20 million, a decrease of -36.96%.